What Our Partners Say

We share a common vision with our partners in wanting to make a difference and develop new and advanced medicines that make a real impact on patients’ lives. Hear what they have to say about their partnering journey with us.

Latest Articles on What Our Partners Say

Chandra Ghose, Founder and CEO of Bioharmony Therapeutics, talks about the urgent need for developing new antimicrobials and the benefits of partnering with Boehringer Ingelheim.

Read more

Our Partners: Warren Center for Neuroscience Drug Discovery at Vanderbilt University

Craig Lindsley, Director of the WCNDD talks about the challenges facing neuroscience researchers and the commitment of Boehringer Ingelheim to this important area.

[Our Partners: Harvard Fibrosis Network](/content/tw/our-partners-harvard-fibrosis-network "Our Partners: Harvard Fibrosis Network"/index.html)

Our Partners: Harvard Fibrosis Network

Brock Reeve, Executive Director of the Harvard Stem Cell Institute, talks about the importance of working together to tackle the challenge of fibrosis.

[Our Partners: ViraTherapeutics](/content/tw/our-partners-viratherapeutics "Our Partners: ViraTherapeutics"/index.html)

Our Partners: ViraTherapeutics

Lisa Egerer, COO and Patrik Erlmann, Head of Research at ViraTherapeutics talk about their partnering journey with Boehringer Ingelheim.